Inventor · disambiguated record
Guanguan Li
Also filed as: LI GUANGUAN
6 granted patents·9 pending applications·6 citations·filing 2016–2024
74Inventor score
Top patents by PatentIndex Score
15 records- 0182US11753412B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with Alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2020·Granted Sep 12, 2023·1 cites·46 claims
- 0279US12180216B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2023·Granted Dec 31, 2024·0 cites·12 claims
- 0378US10259815B2Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2016·Granted Apr 16, 2019·4 cites·22 claims
- 0478US2025179080A1Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing gabaa receptor agonistsUWM RES FOUNDATION INC·Filed 2024·Application pending·0 cites
- 0575US2024366617A1Novel crystalline forms of a nucleoside compound and salts thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0672US10906909B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2017·Granted Feb 2, 2021·1 cites·7 claims
- 0767US12054491B2Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulatorsUWM RES FOUNDATION INC·Filed 2022·Granted Aug 6, 2024·0 cites·12 claims
- 0867US2025049832A1Crystal form of nucleoside compoundSHENZHEN ANTIV PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 0964US2025032526A1Composition, method for preparing same, and use thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1063US2025339377A1Pharmaceutical composition of nucleoside-derived compound, preparation method therefor, and use thereofSHENZHEN ANTIV PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1159US2025066366A1Crystal form of isobutyrate nucleoside compound, and preparation methodSHENZHEN ANTIV PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1253US2024279232A1Use of substituted 5-(4-methyl-6-phenyl-4h-benzo[f]imidazo[1,5-a][1,4] diazepin-3-yl)-1,2,4-oxadiazoles in the treatment of inflammatory conditionsUWM RES FOUNDATION INC·Filed 2021·Application pending·0 cites
- 1350US2024317754A1Methods and modified nucleosides for treating coronavirus infectionsUNIV SOUTHERN SCI & TECH·Filed 2021·Application pending·0 cites
- 1447US11447495B2Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulatorsUWM RES FOUNDATION INC·Filed 2017·Granted Sep 20, 2022·0 cites·18 claims
- 1547US2019300534A1Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guanguan Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →